{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:42:46Z","timestamp":1790800966699,"version":"4.1.0"},"reference-count":263,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02876","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T07:19:41Z","timestamp":1544080781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":182,"title":["Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1"],"prefix":"10.3389","volume":"9","author":[{"given":"Marta","family":"Colomer-Lluch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Moris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G.","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.immuni.2012.08.013","article-title":"Intrinsic cellular defenses against human immunodeficiency viruses","volume":"37","author":"Blanco-Melo","year":"2012","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1073\/pnas.0509996103","article-title":"Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor","volume":"103","author":"Stremlau","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","article-title":"The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein","volume":"3","author":"Van Damme","year":"2008","journal-title":"Cell Host Microbe"},{"key":"B11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","article-title":"Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection","volume":"502","author":"Goujon","year":"2013","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature15400","article-title":"SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef","volume":"526","author":"Usami","year":"2015","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature11433","article-title":"Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11","volume":"491","author":"Li","year":"2012","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/nm.3956","article-title":"MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins","volume":"21","author":"Tada","year":"2015","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.virol.2018.02.003","article-title":"MARCH2 is upregulated in HIV-1 infection and inhibits HIV-1 production through envelope protein translocation or degradation","volume":"518","author":"Zhang","year":"2018","journal-title":"Virology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nri3726","article-title":"Opinion: interactions of innate and adaptive lymphocytes","volume":"14","author":"Gasteiger","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/aid.1995.11.903","article-title":"Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS","volume":"11","author":"Rivi\u00e8re","year":"1995","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B19","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1128\/JVI.73.11.9153-9160.1999","article-title":"Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression","volume":"73","author":"Ogg","year":"1999","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"Goonetilleke","year":"2009","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"S\u00e1ez-Ciri\u00f3n","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"Pereyra","year":"2011","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1073\/pnas.0408223102","article-title":"Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo","volume":"102","author":"Suspene","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1099\/vir.0.80973-0","article-title":"Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases","volume":"86","author":"Mahieux","year":"2005","journal-title":"J Gen Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/JVI.80.2.605-614.2006","article-title":"Restriction of foamy viruses by APOBEC cytidine deaminases","volume":"80","author":"Delebecque","year":"2006","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/JVI.01371-07","article-title":"Species-specific restriction of Apobec3-mediated hypermutation","volume":"82","author":"Browne","year":"2008","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","article-title":"Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity","volume":"15","author":"Newman","year":"2005","journal-title":"Curr Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1128\/MMBR.00040-08","article-title":"Tumultuous relationship between the human immunodeficiency virus type 1 Viral Infectivity Factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors","volume":"73","author":"Henriet","year":"2009","journal-title":"Microbiol Mol Biol Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1074\/jbc.M313093200","article-title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway","volume":"279","author":"Mehle","year":"2004","journal-title":"J Biol Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/gb-2008-9-6-229","article-title":"The AID\/APOBEC family of nucleic acid mutators","volume":"9","author":"Conticello","year":"2008","journal-title":"Genome Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2014.00534","article-title":"AID and APOBECs span the gap between innate and adaptive immunity","volume":"5","author":"Moris","year":"2014","journal-title":"Front Microbiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.1128\/JVI.01089-09","article-title":"Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets","volume":"83","author":"Koning","year":"2009","journal-title":"J Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/icb.2016.28","article-title":"Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation","volume":"94","author":"Oliva","year":"2016","journal-title":"Immunol Cell Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.4049\/jimmunol.177.7.4530","article-title":"STAT1-Independent cell type-specific regulation of antiviral APOBEC3G by IFN-\u03b1","volume":"177","author":"Sarkis","year":"2006","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1182\/blood-2006-10-051763","article-title":"Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1074\/jbc.M610138200","article-title":"Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells","volume":"282","author":"Stopak","year":"2006","journal-title":"J Biol Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ni.2087","article-title":"The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells","volume":"12","author":"Norman","year":"2011","journal-title":"Nat Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1128\/JVI.03399-14","article-title":"Requirement for Fc effector mechanisms in the APOBEC3\/Rfv3-dependent neutralizing antibody response","volume":"89","author":"Halemano","year":"2015","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.4049\/jimmunol.1001143","article-title":"Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo","volume":"185","author":"Santiago","year":"2010","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1002284","DOI":"10.1371\/journal.ppat.1002284","article-title":"Noninfectious retrovirus particles drive the Apobec3\/Rfv3 dependent neutralizing antibody response","volume":"7","author":"Smith","year":"2011","journal-title":"PLoS Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1084\/jem.20091933","article-title":"The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells","volume":"207","author":"Casartelli","year":"2010","journal-title":"J Exp Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/eji.201646603","article-title":"Triggering of TLR-3,\u22124, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells","volume":"47","author":"Cardinaud","year":"2017","journal-title":"Eur J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e93428","DOI":"10.1371\/journal.pone.0093428","article-title":"Positioning of APOBEC3G\/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells","volume":"9","author":"Monajemi","year":"2014","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12981-017-0173-8","article-title":"Evasion of adaptive immunity by HIV through the action of host APOBEC3G\/F enzymes","volume":"14","author":"Grant","year":"2017","journal-title":"AIDS Res Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/QAI.0000000000000689","article-title":"Impact of APOBEC mutations on CD8+ T cell recognition of hiv epitopes varies depending on the restricting HLA","volume":"70","author":"Squires","year":"2015","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B57","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.vaccine.2008.11.084","article-title":"Mucosal immunization in macaques upregulates the innate APOBEC 3G anti-viral factor in CD4(+) memory T cells","volume":"27","author":"Wang","year":"2009","journal-title":"Vaccine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1073\/pnas.0911932107","article-title":"Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques","volume":"107","author":"Sui","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e34433","DOI":"10.1371\/journal.pone.0034433","article-title":"The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV\/SIV immunized SHIV infected macaques","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2567.2011.03524.x","article-title":"B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function","volume":"135","author":"Seidl","year":"2012","journal-title":"Immunology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"43596","DOI":"10.1074\/jbc.C111.317628","article-title":"Aicardi-Gouti\u00e8res syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase","volume":"286","author":"Powell","year":"2011","journal-title":"J Biol Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-015-0174-4","article-title":"SAMHD1 specifically restricts retroviruses through its RNase activity","volume":"12","author":"Choi","year":"2015","journal-title":"Retrovirology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4163","article-title":"SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity","volume":"22","author":"Antonucci","year":"2016","journal-title":"Nat Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.tim.2015.08.002","article-title":"SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction","volume":"23","author":"Ballana","year":"2015","journal-title":"Trends Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"12335","DOI":"10.1128\/JVI.01181-08","article-title":"Characterization of simian immunodeficiency virus SIVSM\/human immunodeficiency virus type 2 Vpx function in human myeloid cells","volume":"82","author":"Goujon","year":"2008","journal-title":"J Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"12550","DOI":"10.1074\/jbc.M112.340711","article-title":"HIV\/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1","volume":"287","author":"Ahn","year":"2012","journal-title":"J Biol Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1742-4690-9-87","article-title":"SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells","volume":"9","author":"Descours","year":"2012","journal-title":"Retrovirology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","article-title":"Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1","volume":"3","author":"Cribier","year":"2013","journal-title":"Cell Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.chom.2013.03.005","article-title":"The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation","volume":"13","author":"White","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.4049\/jimmunol.1400873","article-title":"Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells","volume":"193","author":"Pauls","year":"2014","journal-title":"J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1080\/15384101.2015.1030558","article-title":"Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages","volume":"14","author":"Ruiz","year":"2015","journal-title":"Cell Cycle"},{"key":"B74","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"E3798","DOI":"10.1073\/pnas.1801213115","article-title":"SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-\u03baB and interferon pathways","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B77","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature09337","article-title":"A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells","volume":"467","author":"Manel","year":"2010","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.celrep.2016.07.002","article-title":"Restriction by SAMHD1 limits cGAS\/STING-dependent innate and adaptive immune responses to HIV-1","volume":"16","author":"Maelfait","year":"2016","journal-title":"Cell Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.4049\/jimmunol.1403016","article-title":"SAMHD1 degradation enhances active suppression of dendritic cell maturation by HIV-1","volume":"194","author":"Hertoghs","year":"2015","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1128\/JVI.00069-15","article-title":"SAMHD1 limits HIV-1 antigen presentation by monocyte-derived dendritic cells","volume":"89","author":"Ayinde","year":"2015","journal-title":"J Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1004930","DOI":"10.1371\/journal.ppat.1004930","article-title":"Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers","volume":"11","author":"Martin-Gayo","year":"2015","journal-title":"PLoS Pathog."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/jac\/dku276","article-title":"Increased expression of SAMHD1 in a subset of HIV-1 elite controllers","volume":"69","author":"Riveira-Mu\u00f1oz","year":"2014","journal-title":"J Antimicrob Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/jac\/dku428","article-title":"SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors","volume":"70","author":"Buchanan","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","article-title":"Tetherin inhibits HIV-1 release by directly tethering virions to cells","volume":"139","author":"Perez-Caballero","year":"2009","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1000700","DOI":"10.1371\/journal.ppat.1000700","article-title":"BCA2\/Rabring7 promotes tetherin-dependent HIV-1 restriction","volume":"5","author":"Miyakawa","year":"2009","journal-title":"PLoS Pathog."},{"key":"B86","doi-asserted-by":"publisher","first-page":"35060","DOI":"10.1074\/jbc.M109.058305","article-title":"HIV-1 accessory protein Vpu internalizes cell-surface BST-2\/tetherin through transmembrane interactions leading to lysosomes","volume":"284","author":"Iwabu","year":"2009","journal-title":"J Biol Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1128\/JVI.00242-09","article-title":"Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2\/tetherin via a TrCP-dependent mechanism","volume":"83","author":"Douglas","year":"2009","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1000574","DOI":"10.1371\/journal.ppat.1000574","article-title":"HIV-1 Vpu neutralizes the antiviral factor tetherin\/BST-2 by binding it and directing its beta-TrCP2-dependent degradation","volume":"5","author":"Mangeat","year":"2009","journal-title":"PLoS Pathog."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e1000450","DOI":"10.1371\/journal.ppat.1000450","article-title":"Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking","volume":"5","author":"Mitchell","year":"2009","journal-title":"PLoS Pathog."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4690-8-9","article-title":"\u03b2-TrCP is dispensable for Vpu's ability to overcome the CD317\/Tetherin-imposed restriction to HIV-1 release","volume":"8","author":"Tervo","year":"2011","journal-title":"Retrovirology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e1000856","DOI":"10.1371\/journal.ppat.1000856","article-title":"Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment","volume":"6","author":"Dub\u00e9","year":"2010","journal-title":"PLoS Pathog."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.celrep.2016.10.045","article-title":"LC3C contributes to Vpu-mediated antagonism of BST2\/tetherin restriction on HIV-1 release through a non-canonical autophagy pathway","volume":"17","author":"Madjo","year":"2016","journal-title":"Cell Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"11966","DOI":"10.1128\/JVI.01515-09","article-title":"Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein","volume":"83","author":"Le Tortorec","year":"2009","journal-title":"J Virol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1000429","DOI":"10.1371\/journal.ppat.1000429","article-title":"Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin\/BST2","volume":"5","author":"Jia","year":"2009","journal-title":"PLoS Pathog."},{"key":"B95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.chom.2009.10.004","article-title":"Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains","volume":"6","author":"Sauter","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B96","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chom.2009.05.008","article-title":"Nef proteins from simian immunodeficiency viruses are tetherin antagonists","volume":"6","author":"Zhang","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e1002931","DOI":"10.1371\/journal.ppat.1002931","article-title":"Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities","volume":"8","author":"Cocka","year":"2012","journal-title":"PLoS Pathog."},{"key":"B98","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1128\/JVI.03818-13","article-title":"Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses","volume":"88","author":"Weinelt","year":"2014","journal-title":"J Virol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.chom.2012.10.007","article-title":"Innate sensing of HIV-1 assembly by Tetherin induces NF\u03baB-dependent proinflammatory responses","volume":"12","author":"Gal\u00e3o","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1128\/JVI.02272-12","article-title":"Stimulation of NF-\u03baB activity by the HIV restriction factor BST2","volume":"87","author":"Tokarev","year":"2013","journal-title":"J Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.chom.2014.08.005","article-title":"Retroviral retention activates a Syk-dependent HemITAM in human tetherin","volume":"16","author":"Gal\u00e3o","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B102","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","article-title":"Differential regulation of NF-\u03baB-mediated proviral and antiviral host gene expression by primate lentiviral nef and vpu proteins","volume":"10","author":"Sauter","year":"2015","journal-title":"Cell Rep."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e1005024","DOI":"10.1371\/journal.ppat.1005024","article-title":"Vpu exploits the cross-talk between BST2 and the ILT7 receptor to suppress anti-HIV-1 responses by plasmacytoid dendritic cells","volume":"11","author":"Bego","year":"2015","journal-title":"PLoS Pathog."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1084\/jem.20090547","article-title":"Regulation of TLR7\/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction","volume":"206","author":"Cao","year":"2009","journal-title":"J Exp Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1073\/pnas.1321507111","article-title":"Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity","volume":"111","author":"Arias","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e00219","DOI":"10.1128\/JVI.00219-17","article-title":"BST-2 Expression modulates small CD4-mimetic sensitization of HIV-1-infected cells to antibody-dependent cellular cytotoxicity","volume":"91","author":"Richard","year":"2017","journal-title":"J Virol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor- viral RNA interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J Clin Invest."},{"key":"B108","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1400490","article-title":"Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo","volume":"193","author":"Li","year":"2014","journal-title":"J Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep20425","article-title":"Tetherin\/BST-2 promotes dendritic cell activation and function during acute retrovirus infection","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1002388","DOI":"10.1371\/journal.pgen.1002388","article-title":"Identification of a genomic reservoir for new trim genes in primate genomes","volume":"7","author":"Han","year":"2011","journal-title":"PLoS Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM famiy proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tibs.2017.01.002","article-title":"TRIM family proteins: roles in autophagy, immunity, and carcinogenesis","volume":"42","author":"Hatakeyama","year":"2017","journal-title":"Trends Biochem Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jmb.2013.12.005","article-title":"TRIMmunity: The roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity","volume":"426","author":"Rajsbaum","year":"2014","journal-title":"J Mol Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","article-title":"TRIM family proteins: retroviral restriction and antiviral defence","volume":"3","author":"Nisole","year":"2005","journal-title":"Nat Rev Microbiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1073\/pnas.0409853102","article-title":"Positive selection of primate TRIM5 identifies a critical species-specific retroviral restriction domain","volume":"102","author":"Sawyer","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1128\/JVI.79.5.3139-3145.2005","article-title":"Species-specific variation in the B30","volume":"79","author":"Stremlau","year":"2005","journal-title":"J Virol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cub.2004.12.042","article-title":"A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction","volume":"15","author":"Yap","year":"2005","journal-title":"Curr Biol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.molcel.2004.12.001","article-title":"Retrovirus restriction factors","volume":"16","author":"Goff","year":"2004","journal-title":"Mol Cell"},{"key":"B119","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature02777","article-title":"Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1","volume":"430","author":"Sayah","year":"2004","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1128\/JVI.79.14.8969-8978.2005","article-title":"Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity","volume":"79","author":"Perez-Caballero","year":"2005","journal-title":"J Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"26933","DOI":"10.1074\/jbc.M502145200","article-title":"The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5\u03b1","volume":"280","author":"Javanbakht","year":"2005","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature20567","article-title":"Receptor usage dictates HIV-1 restriction by human TRIM5\u03b1 in dendritic cell subsets","volume":"540","author":"Ribeiro","year":"2016","journal-title":"Nature"},{"key":"B123","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.celrep.2015.12.039","article-title":"Endogenous TRIM5\u03b1 function is regulated by SUMOylation and nuclear sequestration for efficient innate sensing in dendritic cells","volume":"14","author":"Portilho","year":"2016","journal-title":"Cell Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/eji.200737916","article-title":"Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells","volume":"38","author":"Rajsbaum","year":"2008","journal-title":"Eur J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1073\/pnas.0402876101","article-title":"Trim5alpha protein restricts both HIV-1 and murine leukemia virus","volume":"101","author":"Yap","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B126","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1073\/pnas.0709003105","article-title":"Independent evolution of an antiviral TRIMCyp in rhesus macaques","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B127","doi-asserted-by":"publisher","first-page":"19134","DOI":"10.1073\/pnas.0605838103","article-title":"Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha","volume":"103","author":"Newman","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B128","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1073\/pnas.0402361101","article-title":"Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha","volume":"101","author":"Hatziioannou","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B129","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1073\/pnas.0402474101","article-title":"The human and African green monkey TRIM5\u03b1 genes encode Ref1 and Lv1 retroviral restriction factor activities","volume":"101","author":"Keckesova","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virol.2006.06.031","article-title":"Effects of human TRIM5\u03b1 polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection","volume":"354","author":"Javanbakht","year":"2006","journal-title":"Virology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cub.2005.11.045","article-title":"High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5\u03b1 in humans","volume":"16","author":"Sawyer","year":"2006","journal-title":"Curr Biol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3004","article-title":"Impact of cellular restriction gene (TRIM5\u03b1, BST-2) polymorphisms on the acquisition of HIV-1 and disease progression","author":"Singh","year":"2017","journal-title":"J Gene Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12026-016-8810-1","article-title":"TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil","volume":"64","author":"Celerino da Silva","year":"2016","journal-title":"Immunol Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1097\/QAD.0b013e32833b5256","article-title":"A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort","volume":"24","author":"Price","year":"2010","journal-title":"AIDS"},{"key":"B135","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/JVI.80.5.2463-2471.2006","article-title":"Genetic association of the antiviral restriction factor TRIM5\u03b1 with human immunodeficiency virus type 1 infection","volume":"80","author":"Speelmon","year":"2006","journal-title":"J Virol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1371\/journal.ppat.0040018","article-title":"The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection","volume":"4","author":"Van Manen","year":"2008","journal-title":"PLoS Pathog."},{"key":"B137","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1128\/JVI.05201-11","article-title":"Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5\u03b1, linking intrinsic and acquired immunity","volume":"85","author":"Battivelli","year":"2011","journal-title":"J Virol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e1003214","DOI":"10.1371\/journal.ppat.1003214","article-title":"Fates of retroviral core components during unrestricted and TRIM5-restricted infection","volume":"9","author":"Kutluay","year":"2013","journal-title":"PLoS Pathog."},{"key":"B139","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.1128\/JVI.00210-10","article-title":"TRIM5\u03b1 disrupts the structure of assembled HIV-1 capsid complexes in vitro","volume":"84","author":"Black","year":"2010","journal-title":"J Virol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1128\/JVI.02318-06","article-title":"The human TRIM5\u03b1 restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid","volume":"81","author":"Perron","year":"2007","journal-title":"J Virol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1128\/JVI.01307-09","article-title":"A B-box 2 surface patch important for TRIM5\u03b1 self-association, capsid binding avidity, and retrovirus restriction","volume":"83","author":"Diaz-Griffero","year":"2009","journal-title":"J Virol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"11682","DOI":"10.1128\/JVI.01562-08","article-title":"Biochemical characterization of a recombinant TRIM5\u03b1 protein that restricts human immunodeficiency virus type 1 replication","volume":"82","author":"Langelier","year":"2008","journal-title":"J Virol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1073\/pnas.1013426108","article-title":"Hexagonal assembly of a restricting TRIM5alpha protein","volume":"108","author":"Ganser-Pornillos","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e01563","DOI":"10.1128\/JVI.01563-17","article-title":"A general model for retroviral capsid pattern recognition by TRIM5 proteins","volume":"92","author":"Wagner","year":"2017","journal-title":"J Virol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1128\/JVI.01052-06","article-title":"Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins","volume":"80","author":"Anderson","year":"2006","journal-title":"J Virol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1083\/jcb.200706154","article-title":"Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha","volume":"180","author":"Campbell","year":"2008","journal-title":"J Cell Biol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e1000074","DOI":"10.1371\/journal.ppat.1000074","article-title":"Proteasomal degradation of TRIM5\u03b1 inhibits during retrovirus restriction","volume":"4","author":"Rold","year":"2008","journal-title":"PLoS Pathog."},{"key":"B148","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1073\/pnas.0510483103","article-title":"Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection","volume":"103","author":"Wu","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B149","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature09976","article-title":"TRIM5 is an innate immune sensor for the retrovirus capsid lattice","volume":"472","author":"Pertel","year":"2011","journal-title":"Nature"},{"key":"B150","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.celrep.2015.06.072","article-title":"RING dimerization links higher-order assembly of TRIM5\u03b1 to synthesis of K63-linked polyubiquitin","volume":"12","author":"Yudina","year":"2015","journal-title":"Cell Rep."},{"key":"B151","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.virol.2010.09.018","article-title":"Human Trim5\u03b1 has additional activities that are uncoupled from retroviral capsid recognition","volume":"409","author":"Tareen","year":"2011","journal-title":"Virology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1128\/JVI.01804-12","article-title":"TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity","volume":"87","author":"Uchil","year":"2013","journal-title":"J Virol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cytogfr.2014.08.001","article-title":"InTRIMsic immunity: positive and negative regulation of immune signaling by tripartite motif proteins","volume":"25","author":"Versteeg","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"B154","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2012.11.013","article-title":"The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors","volume":"38","author":"Versteeg","year":"2013","journal-title":"Immunity"},{"key":"B155","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.it.2004.10.001","article-title":"Evolution of innate and adaptive immunity: can we draw a line?","volume":"25","author":"Flajnik","year":"2004","journal-title":"Trends Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"e95805","DOI":"10.1371\/journal.pone.0095805","article-title":"Tripartite motif-containing protein 30 modulates TCR-activated proliferation and effector functions in CD4+ T cells","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS ONE"},{"key":"B157","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.1128\/JVI.00819-16","article-title":"Nonhuman TRIM5 variants enhance recognition of HIV-1-infected cells by CD8 + T cells","volume":"90","author":"Jimenez-Moyano","year":"2016","journal-title":"J Virol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/cmi.12262","article-title":"Identification of an endocytic signal essential for the antiviral action of IFITM3","volume":"16","author":"Jia","year":"2014","journal-title":"Cell Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1074\/jbc.M114.630780","article-title":"A sorting signal suppresses IFITM1 restriction of viral entry","volume":"290","author":"Li","year":"2015","journal-title":"J Biol Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI84889","article-title":"The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis","volume":"127","author":"Stacey","year":"2017","journal-title":"J Clin Invest."},{"key":"B161","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ni.2525","article-title":"Enhanced survival of lung tissue-resident memory CD8 + T cells during infection with influenza virus due to selective expression of IFITM3","volume":"14","author":"Wakim","year":"2013","journal-title":"Nat Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/07853890310016324","article-title":"The ubiquitin-proteasome pathway","volume":"36","author":"Roos-Mattjus","year":"2004","journal-title":"Ann Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2015.09.005","article-title":"Interplay between the virus and the ubiquitin-proteasome system: molecular mechanism of viral pathogenesis","volume":"17","author":"Luo","year":"2016","journal-title":"Curr Opin Virol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1073\/pnas.97.24.13057","article-title":"Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2","volume":"97","author":"Schubert","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B165","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/v9110322","article-title":"Hijacking of the ubiquitin\/proteasome pathway by the HIV auxiliary proteins","volume":"9","author":"Seissler","year":"2017","journal-title":"Viruses"},{"key":"B166","doi-asserted-by":"publisher","first-page":"15920","DOI":"10.1074\/jbc.M010533200","article-title":"The human immunodeficiency virus type 1 Vpu protein inhibits NF-\u03baB activation by interfering with \u03b2TrCP-mediated degradation of I\u03baB","volume":"276","author":"Bour","year":"2001","journal-title":"J Biol Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1084\/jem.185.5.909","article-title":"Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization","volume":"185","author":"Tobery","year":"1997","journal-title":"J Exp Med."},{"key":"B168","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4049\/jimmunol.180.1.372","article-title":"Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation","volume":"180","author":"Goldwich","year":"2008","journal-title":"J Immunol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1128\/JVI.00579-12","article-title":"T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected indian rhesus macaques","volume":"87","author":"Champiat","year":"2013","journal-title":"J Virol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.virol.2005.12.040","article-title":"Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5","volume":"349","author":"Diaz-Griffero","year":"2006","journal-title":"Virology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1600-0854.2012.01381.x","article-title":"Recruitment and dynamics of proteasome association with rhTRIM5\u03b1 cytoplasmic complexes during HIV-1 infection","volume":"13","author":"Danielson","year":"2012","journal-title":"Traffic"},{"key":"B172","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-4690-8-93","article-title":"TRIM5\u03b1 associates with proteasomal subunits in cells while in complex with HIV-1 virions","volume":"8","author":"Lukic","year":"2011","journal-title":"Retrovirology"},{"key":"B173","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.coviro.2012.02.003","article-title":"TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling","volume":"2","author":"Gr\u00fctter","year":"2012","journal-title":"Curr Opin Virol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v9080222","article-title":"Inhibitors of deubiquitinating enzymes block HIV-1 replication and augment the presentation of gag-derived MHC-I epitopes","volume":"9","author":"Setz","year":"2017","journal-title":"Viruses"},{"key":"B175","doi-asserted-by":"publisher","first-page":"10014","DOI":"10.1073\/pnas.1507534112","article-title":"Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21","volume":"112","author":"Fletcher","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.201490361","article-title":"TRIM5\u03b1 requires Ube2W to anchor Lys63-linked ubiquitin chains and restrict reverse transcription","volume":"34","author":"Fletcher","year":"2015","journal-title":"EMBO J."},{"key":"B177","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.021908.132537","article-title":"Enhancing immunity through autophagy","volume":"27","author":"M\u00fcnz","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4049\/jimmunol.1102108","article-title":"Autophagy: an emerging immunological paradigm","volume":"189","author":"Deretic","year":"2012","journal-title":"J Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1146\/annurev-immunol-020711-074948","article-title":"Autophagy and the immune system","volume":"30","author":"Kuballa","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.3273","article-title":"Autophagy and autophagy-related proteins in the immune system","volume":"16","author":"Shibutani","year":"2015","journal-title":"Nat Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12613","article-title":"Autophagy limits activation of the inflammasomes","volume":"281","author":"Takahama","year":"2018","journal-title":"Immunol Rev."},{"key":"B182","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.it.2016.08.017","article-title":"Autophagy beyond intracellular MHC class II antigen presentation","volume":"37","author":"M\u00fcnz","year":"2016","journal-title":"Trends Immunol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2006.10.018","article-title":"Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes","volume":"26","author":"Schmid","year":"2007","journal-title":"Immunity"},{"key":"B184","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1104904","article-title":"Endogenous MHC class II processing of a viral nuclear antigen after autophagy","volume":"307","author":"Paludan","year":"2005","journal-title":"Science"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ni.1720","article-title":"Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection","volume":"10","author":"English","year":"2009","journal-title":"Nat Immunol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1182\/blood-2012-01-402404","article-title":"Autophagy mediates transporter associated with antigen processing-independent presentation of viral epitopes through MHC class I pathway","volume":"120","author":"Tey","year":"2012","journal-title":"Blood"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.10.021","article-title":"Role of autophagy in MHC class I-restricted antigen presentation","author":"Van Kaer","year":"2017","journal-title":"Mol Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2018.04.014","article-title":"Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation","volume":"52","author":"Keller","year":"2018","journal-title":"Curr Opin Immunol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"e1006787","DOI":"10.1371\/journal.ppat.1006787","article-title":"TRIM proteins: new players in virus-induced autophagy","volume":"14","author":"Sparrer","year":"2018","journal-title":"PLoS Pathog."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41564-017-0017-2","article-title":"TRIM23 mediates virus-induced autophagy via activation of TBK1","volume":"2","author":"Sparrer","year":"2017","journal-title":"Nat Microbiol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1128\/JVI.02412-09","article-title":"p62\/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5\u03b1","volume":"84","author":"O'Connor","year":"2010","journal-title":"J Virol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.devcel.2014.06.013","article-title":"TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition","volume":"30","author":"Mandell","year":"2014","journal-title":"Dev Cell"},{"key":"B193","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/15548627.2016.1154254","article-title":"TRIM-directed selective autophagy regulates immune activation","volume":"13","author":"Kimura","year":"2017","journal-title":"Autophagy"},{"key":"B194","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.immuni.2010.04.011","article-title":"Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses","volume":"32","author":"Blanchet","year":"2010","journal-title":"Immunity"},{"key":"B195","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4049\/jimmunol.1600286","article-title":"HIV-infected dendritic cells present endogenous MHC class II\u2013restricted antigens to HIV-specific CD4 + T cells","volume":"197","author":"Coulon","year":"2016","journal-title":"J Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1128\/JVI.03033-15","article-title":"TRIM5\u03b1 degradation via autophagy is not required for retroviral restriction","volume":"90","author":"Imam","year":"2016","journal-title":"J Virol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12013-013-9623-7","article-title":"Selective autophagy: talking with the UPS","volume":"67","author":"Park","year":"2013","journal-title":"Cell Biochem Biophys."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","article-title":"Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems","volume":"584","author":"Korolchuk","year":"2010","journal-title":"FEBS Lett."},{"key":"B199","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cell.2016.05.078","article-title":"An ER-associated pathway defines endosomal architecture for controlled cargo transport","volume":"166","author":"Jongsma","year":"2016","journal-title":"Cell"},{"key":"B200","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0092-8674(01)00434-2","article-title":"Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I","volume":"106","author":"Katzmann","year":"2001","journal-title":"Cell"},{"key":"B201","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","article-title":"Ubiquitin: same molecule, different degradation pathways","volume":"143","author":"Clague","year":"2010","journal-title":"Cell"},{"key":"B202","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1128\/JVI.01447-10","article-title":"Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin\/BST-2-mediated restriction in T cells","volume":"84","author":"Jolly","year":"2010","journal-title":"J Virol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"e1000955","DOI":"10.1371\/journal.ppat.1000955","article-title":"Tetherin restricts productive HIV-1 cell-to-cell transmission","volume":"6","author":"Casartelli","year":"2010","journal-title":"PLoS Pathog."},{"key":"B204","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-4690-7-115","article-title":"Tetherin restricts direct cell-to-cell infection of HIV-1","volume":"7","author":"Kuhl","year":"2010","journal-title":"Retrovirology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1242\/jcs.003343","article-title":"Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif","volume":"120","author":"Rollason","year":"2007","journal-title":"J Cell Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/blood-2006-02-006361","article-title":"Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer","volume":"108","author":"Moris","year":"2006","journal-title":"Blood"},{"key":"B207","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1570162X14999160224102752","article-title":"Tetherin\/BST-2: restriction factor or immunomodulator?","volume":"14","author":"Li","year":"2016","journal-title":"Curr HIV Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B209","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"B210","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.virol.2007.06.010","article-title":"The interferon-induced expression of APOBEC3G in human blood\u2013brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system","volume":"367","author":"Argyris","year":"2007","journal-title":"Virology"},{"key":"B211","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1099\/vir.0.83530-0","article-title":"APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells","volume":"89","author":"Wang","year":"2008","journal-title":"J Gen Virol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.4049\/jimmunol.1201184","article-title":"IFN-\u03b1 induces APOBEC3G, F, and A in immature dendritic dells and limits HIV-1 spread to CD4+ T cells","volume":"190","author":"Mohanram","year":"2013","journal-title":"J Immunol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"10659","DOI":"10.1128\/JVI.05524-11","article-title":"Upregulation of BST-2\/tetherin by HIV infection in vivo","volume":"85","author":"Homann","year":"2011","journal-title":"J Virol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1074\/jbc.M116.752584","article-title":"Interferons induce expression of SAMHD1 in monocytes through down-regulation of miR-181a and miR-30a","volume":"292","author":"Riess","year":"2017","journal-title":"J Biol Chem."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2217\/fmb.12.81","article-title":"SAMHD1: a novel antiviral factor in intrinsic immunity","volume":"7","author":"Chen","year":"2012","journal-title":"Future Microbiol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-9-105","article-title":"SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons","volume":"9","author":"St Gelais","year":"2012","journal-title":"Retrovirology"},{"key":"B217","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.1128\/JVI.00419-07","article-title":"Alpha interferon enhances TRIM5\u03b1-mediated antiviral activities in human and rhesus monkey cells","volume":"81","author":"Sakuma","year":"2007","journal-title":"J Virol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/jir.2009.0090","article-title":"Interferon-\u03b1 produces significant decreases in HIV load","volume":"30","author":"Tavel","year":"2010","journal-title":"J Interf Cytokine Res."},{"key":"B219","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.1111573109","article-title":"Role of retroviral restriction factors in the interferon-\u03b1-mediated suppression of HIV-1 in vivo","volume":"109","author":"Pillai","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B221","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1128\/JVI.02687-13","article-title":"Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo","volume":"88","author":"Abdel-Mohsen","year":"2014","journal-title":"J Virol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1128\/JVI.00451-16","article-title":"Interferon alpha subtype-specific suppression of HIV-1 infection in vivo","volume":"90","author":"Lavender","year":"2016","journal-title":"J Virol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01431","article-title":"The significance of type-I interferons in the pathogenesis and therapy of human immunodeficiency virus 1 infection","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molmed.2018.03.004","article-title":"A new class of antiretroviral enabling innate immunity by protecting APOBEC3 from HIV Vif-dependent degradation","volume":"24","author":"Bennett","year":"2018","journal-title":"Trends Mol Med."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep18499","article-title":"A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2","volume":"5","author":"Mi","year":"2015","journal-title":"Sci Rep."},{"key":"B226","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1016\/j.bmc.2013.03.001","article-title":"Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides","volume":"21","author":"Reingewertz","year":"2013","journal-title":"Bioorganic Med Chem."},{"key":"B227","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.bbamem.2015.12.028","article-title":"Probing interactions of Vpu from HIV-1 with amiloride-based compounds","volume":"1858","author":"Rosenberg","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B228","doi-asserted-by":"publisher","first-page":"10504","DOI":"10.1074\/jbc.M114.626903","article-title":"Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein","volume":"290","author":"Pery","year":"2015","journal-title":"J Biol Chem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"16546","DOI":"10.1074\/jbc.M109.085308","article-title":"Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G","volume":"285","author":"Cen","year":"2010","journal-title":"J Biol Chem."},{"key":"B230","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1038\/ncomms7945","article-title":"ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction","volume":"6","author":"Miyakawa","year":"2015","journal-title":"Nat Commun."},{"key":"B231","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2015.07.009","article-title":"Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex","volume":"122","author":"Zhang","year":"2015","journal-title":"Antiviral Res."},{"key":"B232","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1128\/JVI.06957-11","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC","volume":"86","author":"Zuo","year":"2012","journal-title":"J Virol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.virol.2011.04.009","article-title":"Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317","volume":"416","author":"Bolduan","year":"2011","journal-title":"Virology"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1286-4579(03)00191-6","article-title":"The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release","volume":"5","author":"Bour","year":"2003","journal-title":"Microbes Infect."},{"key":"B235","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0014-5793(96)01146-5","article-title":"Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells","volume":"398","author":"Schubert","year":"1996","journal-title":"FEBS Lett."},{"key":"B236","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1110\/ps.073041107","article-title":"Conformational changes induced by a single amino acid substitution in the trans -membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs","volume":"16","author":"Park","year":"2007","journal-title":"Protein Sci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4+ T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat Med."},{"key":"B238","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1742-4690-9-88","article-title":"SAMHD1: a new contributor to HIV-1 restriction in resting CD4+ T-cells","volume":"9","author":"Wu","year":"2012","journal-title":"Retrovirology"},{"key":"B239","doi-asserted-by":"publisher","first-page":"e0169052","DOI":"10.1371\/journal.pone.0169052","article-title":"Substrates and inhibitors of SAMHD1","volume":"12","author":"Hollenbaugh","year":"2017","journal-title":"PLoS ONE"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00819-18","article-title":"SAMHD1 phosphorylation coordinates the anti-HIV-1 response by diverse interferons and tyrosine kinase inhibition","volume":"9","author":"Szaniawski","year":"2018","journal-title":"MBio"},{"key":"B241","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jac\/dkv363","article-title":"Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1","volume":"71","author":"Badia","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B242","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1097\/QAD.0000000000000399","article-title":"Palbociclib, a selective inhibitor of cyclin-dependent kinase4\/6, blocks HIV-1 reverse transcription through the control of sterile a motif and HD domain-containing protein-1 (SAMHD1) activity","volume":"28","author":"Pauls","year":"2014","journal-title":"AIDS"},{"key":"B244","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bcp.2015.02.009","article-title":"Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription","volume":"94","author":"Bermejo","year":"2015","journal-title":"Biochem Pharmacol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15252\/embj.201796880","article-title":"DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages","volume":"37","author":"Mlcochova","year":"2017","journal-title":"EMBO J."},{"key":"B246","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.virol.2007.04.005","article-title":"The design of artificial retroviral restriction factors","volume":"365","author":"Yap","year":"2007","journal-title":"Virology"},{"key":"B247","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/1570162X14999160224103555","article-title":"HIV-1 capsid inhibitors as antiretroviral agents","volume":"14","author":"Thenin-Houssier","year":"2016","journal-title":"Curr HIV Res."},{"key":"B248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00343","article-title":"Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches","volume":"4","author":"Santa-Marta","year":"2013","journal-title":"Front Immunol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol Cell"},{"key":"B250","doi-asserted-by":"publisher","first-page":"e1003299","DOI":"10.1371\/journal.ppat.1003299","article-title":"Vpu binds directly to tetherin and displaces it from nascent virions","volume":"9","author":"McNatt","year":"2013","journal-title":"PLoS Pathog."},{"key":"B251","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/v6010243","article-title":"Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1","volume":"6","author":"Chan","year":"2014","journal-title":"Viruses"},{"key":"B252","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1128\/JVI.00270-06","article-title":"Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection","volume":"80","author":"Li","year":"2006","journal-title":"J Virol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/gt.2010.40","article-title":"Generation of human TRIM5\u03b1 mutants with high HIV-1 restriction activity","volume":"17","author":"Pham","year":"2010","journal-title":"Gene Ther."},{"key":"B254","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1089\/hum.2015.059","article-title":"Preclinical assessment of mutant human TRIM5\u03b1 as an anti-HIV-1 transgene","volume":"26","author":"Jung","year":"2015","journal-title":"Hum Gene Ther."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/mt.2014.52","article-title":"Stabilized human TRIM5\u03b1 protects human T cells from HIV-1 infection","volume":"22","author":"Richardson","year":"2014","journal-title":"Mol Ther."},{"key":"B256","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/hum.2007.108","article-title":"Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue","volume":"19","author":"Anderson","year":"2008","journal-title":"Hum Gene Ther."},{"key":"B257","doi-asserted-by":"publisher","first-page":"13324","DOI":"10.1073\/pnas.0404640101","article-title":"A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1","volume":"101","author":"Nisole","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B258","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI39354","article-title":"Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components","volume":"119","author":"Neagu","year":"2009","journal-title":"J Clin Invest."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1089\/hum.2012.083","article-title":"Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor","volume":"23","author":"Chan","year":"2012","journal-title":"Hum Gene Ther."},{"key":"B260","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/mt.2009.187","article-title":"Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy","volume":"17","author":"Anderson","year":"2009","journal-title":"Mol Ther."},{"key":"B261","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/JVI.06300-11","article-title":"Generation of an HIV-1-resistant immune system with CD34+ hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector","volume":"86","author":"Walker","year":"2012","journal-title":"J Virol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3389\/fimmu.2017.01616","article-title":"Targeting TRIM5\u03b1 in HIV cure strategies for the CRISPR-Cas9 era","volume":"8","author":"Weatherley","year":"2017","journal-title":"Front Immunol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"e0191709","DOI":"10.1371\/journal.pone.0191709","article-title":"Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1","volume":"13","author":"Dufour","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02876\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T23:08:24Z","timestamp":1605568104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02876\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":263,"alternative-id":["10.3389\/fimmu.2018.02876"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02876","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"article-number":"2876"}}